Around the Regions

Premium

Report: Ohio's Third Frontier Yields $6.6B in Economic Activity, Near 10-to-One Return on State Spending

Ohio's $1.6 billion Third Frontier research and tech-commercialization effort, set to expire in 2012, generated $6.6 billion of economic activity, 41,300 total jobs, and $2.4 billion in employee wages and benefits following $681 million in state spending on the program between 2003 and 2008, according to a report released this week at a meeting of the Ohio Third Frontier Advisory Board and Commission.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

Science speaks with the University of Michigan's Jedidiah Carlson, who has tracked population genetic discussions at white nationalist sites.

Gene therapies could qualify for a faster US Food and Drug Administration approval process, according to Stat News.

NPR reports that the US House of Representatives has passed a bill to enable terminally ill patients access to experimental drugs.

In Genome Research this week: inversion variants mapped in human, non-human primate genomes; transcriptome profiling of maize, sorghum; and more.